Skip to main content

Table 3 Stepward forward regression analysis of PAI-1 and metabolic parameters, bone mineral density and therapy

From: Plasminogen activator inhibitor-1 concentrations and bone mineral density in postmenopausal women with type 2 diabetes mellitus

Dependent variable: PAI-1 Beta p adjusted R 2
Triglycerides (mmol/L) 0,314 0,0002 0,574
Insulin (mIU/L) 0,250 0,0033  
Pyrilinks (nMPD/mMc) −0,308 0,0002
BMI (kg/m2) 0,310 0,0035
Waist circumference (cm) −0,278 0,0097
Age (years) −0,364 0,0201
Diabetes duration (years) −0,187 0,0185
Menopause duration (years) 0,283 0,0688
Beta blockers (%) 0,224 0,0045  
  1. PAI-1 plasminogen activator inhibitor 1, BMI body mass indeks